Mechanisms of Type 2 Inflammation Mid-Career Award
Limited submission
Mechanisms of Type 2 Inflammation Mid-Career Award supports mid-career investigators’ basic, clinical, or translational research to reveal new insights into Type 2 inflammatory skin disorders.
Funder: Dermatology Foundation
Due Dates: December 1, 2026 (Application, 11:59 p.m. CST) | January 1, 2027 (Renewal)
Funding Amounts: $100,000 annually for up to three years
Summary: Supports mid-career investigators’ basic, clinical, or translational research into mechanisms of Type 2 inflammatory skin disorders.
Key Information: Applicants must commit at least 75% of their time to research and hold a primary dermatology appointment.
Description
The Dermatology Foundation’s Mechanisms of Type 2 Inflammation Mid-Career Award, sponsored by Sanofi-Regeneron, supports outstanding investigators with an established record of excellence in basic, clinical, or translational science. It funds hypothesis-driven, three-year projects expected to generate new insights into dermatological issues associated with mechanisms of Type 2 inflammation.
The award is intended to advance exceptional mid-career investigators’ research and academic careers in dermatology. Applicants are expected to actively pursue “R” funding to further their work. The Foundation encourages applicants from minority populations and research concerning health issues affecting racial minorities, sexual and gender/LGBTQ minorities, and underserved or disadvantaged populations.
